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ABSTRACT
The target of rapamycin (TOR) kinase is an evolu-
tionarily conserved key regulator of eukaryotic cell
growth and proliferation. Recently, it has been
reported that inhibition of TOR signaling pathway
can delay aging and extend lifespan in several eu-
karyotic organisms, but how lifespan extension is
mediated by inhibition of TOR signaling is poorly
understood. Here we report that rapamycin treat-
ment and nitrogen starvation, both of which cause
inactivation of TOR complex 1 (TORC1), lead to
enhanced association of Sir2 with ribosomal DNA
(rDNA) in Saccharomyces cerevisiae. TORC1 inhib-
ition increases transcriptional silencing of RNA
polymerase II-transcribed gene integrated at the
rDNA locus and reduces homologous recombin-
ation between rDNA repeats that causes formation
of toxic extrachromosomal rDNA circles. In addition,
TORC1 inhibition induces deacetylation of histones
at rDNA. We also found that Pnc1 and Net1 are
required for enhancement of association of Sir2
with rDNA under TORC1 inhibition. Taken together,
our findings suggest that inhibition of TORC1 signal-
ing stabilizes the rDNA locus by enhancing associ-
ation of Sir2 with rDNA, thereby leading to extension
of replicative lifespan in S. cerevisiae.
INTRODUCTION
In eukaryotic cells, ribosomal DNA (rDNA) forms the
basis of nucleolus where synthesis and processing of ribo-
somal RNA (rRNA) and ribosome assembly occur. In the
budding yeast Saccharomyces cerevisiae, 100–200 copies of
a 9.1-kb rDNA repeat exist as a tandem array on chromo-
some XII (1). Each rDNA repeat consists of the RNA
polymerase (Pol) I-transcribed 35S rRNA gene and the
non-transcribed spacer (NTS), which is divided by the
Pol III-transcribed 5S rRNA gene into NTS1 and NTS2
(Figure 1B). Cells control the protein biosynthetic
capacity by regulating transcription of rRNA genes and
ribosomal protein genes and altering ribosome biosynthe-
sis in response to nutrient availability (2–4). rRNA tran-
scription is a critical initial step for ribosome biosynthesis
and represents  60% of total transcription in rapidly
growing yeast cells.
Because of the highly repetitive nature, rDNA array is
intrinsically unstable and an easy target for homologous
recombination. A primary cause of aging in S. cerevisiae is
known to be homologous recombination between rDNA
repeats, which leads to formation of extrachromosomal
rDNA circles that accumulate to toxic levels in mother
cells (5). Under normal conditions, however, rDNA
repeats remain relatively stable because rDNA recombin-
ation is negatively regulated through a mechanism
referred to as rDNA silencing. In S. cerevisiae, Sir2
suppresses Pol II-dependent transcription at the rDNA
locus (6). It has been reported that Sir2 can forestall
aging by stabilizing the rDNA locus (5,7,8). Sir2 is an
NAD
+-dependent histone deacetylase and its activity is
necessary for spreading of silencing complexes along the
N-terminal tails of histones (9–11). Sir2 has been identiﬁed
as a subunit of an rDNA silencing complex called RENT
(regulator of nucleolar silencing and telophase exit) (12).
Net1, another subunit of the RENT complex, recruits Sir2
to rDNA and is also required for rDNA silencing (13).
Fob1 physically interacts with Net1 and Sir2 and has been
shown to be required in rDNA silencing by recruiting
Net1 and Sir2 to the NTS1 (6). It has also been shown
that Net1 and Sir2 are associated with two regions of
rDNA, the NTS1 and the NTS2/Pol I promoter (6). The
NTS1 contains replication fork block and cis-element
required for Fob1-dependent rDNA recombination
(14–17) and the NTS2 overlaps with the Pol I transcrip-
tion initiation region. In cells lacking Fob1, rDNA
silencing is abolished speciﬁcally at the NTS1 (6).
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phosphatidylinositol kinase-related kinase highly
conserved in all eukaryotes (18,19) and a key regulator
of ribosome biogenesis in response to nutrient conditions
(20–22). In S. cerevisiae, TOR kinases are encoded by
TOR1 and TOR2, and they exist in two functionally
distinct multi-protein complexes, TOR complex 1
(TORC1) and TOR complex 2 (TORC2) (23). An im-
munosuppressive and anticancer drug rapamycin speciﬁc-
ally inhibits TORC1 and leads to a rapid decrease in the
expression of ribosomal components, including 35S rRNA
(by Pol I), ribosomal proteins (by Pol II) and 5S rRNA
(by Pol III) (24–26). It has been reported that inhibition of
TORC1 signaling by rapamycin can delay aging and
extend lifespan in S. cerevisiae, Caenorhabditis elegans
and Drosophila melanogaster (27–30). A recent study
has shown that rapamycin can also extend lifespan in
genetically heterogeneous mice (31).
The mechanism by which inhibition of TORC1 signal-
ing delays aging and extends lifespan is poorly under-
stood, but it has been proposed that it may involve
alteration of ribosome assembly and translation
(28,29,32,33). Whether Sir2 plays a role in rDNA stability
and lifespan extension in S. cerevisiae under inhibition of
TORC1 signaling is somewhat controversial; deletion of
TOR1 has been shown to signiﬁcantly increase lifespan
but have no effect on the Sir2 activity (29), whereas a
recent study has reported that TORC1 inhibition by
rapamycin increases the Sir2 activity and stabilizes the
rDNA locus (30).
To gain further insight into the relationship between
TORC1 signaling and rDNA stability, we analyzed asso-
ciation of Sir2 with rDNA at high resolution under
rapamycin treatment and nitrogen starvation. Here we
report that association of Sir2 with rDNA increases
under rapamycin treatment and nitrogen starvation, and
inhibition of TORC1 signaling promotes transcriptional
silencing of Pol II-transcribed gene at the rDNA locus
and reduces homologous recombination between rDNA
repeats. We also show that TORC1 inhibition induces
deacetylation of histones at rDNA, and Pnc1 and Net1
are required for enhancement of association of Sir2 with
rDNA under TORC1 inhibition. Our results propose a
model in which TORC1 inhibition stabilizes the rDNA
locus by enhancing Sir2 binding to rDNA and thus
extends lifespan in yeast.
MATERIALS AND METHODS
Yeast strains, media and reagents
Yeast strains used in this study are listed in Supplementary
Table S1. Yeast strains were genetically manipulated
according to the one-step PCR-mediated gene targeting
procedure as previously described (34). Strains for
analyzing mURA3 silencing and loss of ADE2 in the
rDNA locus have been described previously (35). Yeast
transformation was performed using the lithium acetate
method (36), and proper integration was conﬁrmed by
PCR. For overexpression of PNC1 and SIR2, the coding
sequences for PNC1-GFP and SIR2-TAP were ampliﬁed
by PCR and cloned into the XhoI and HindIII sites of the
p416GPD vector (37). Rich medium (yeast extract,
peptone, glucose; YPD) and synthetic complete (SC)
medium lacking appropriate amino acids for selection
were prepared as described earlier (38). Rapamycin
(Tecoland) was stored in DMSO at a concentration of
2mg/ml and used at a ﬁnal concentration of 200ng/ml.
For rapamycin treatment, exponentially growing cells
(OD600=1.0) in SC medium were treated with 200ng/
ml rapamycin for 1h. For nitrogen starvation, cells
grown to log phase (OD600=1.0) in SC medium were
washed with distilled water and incubated in nitrogen-
depleted medium (0.17% yeast nitrogen base without
amino acids and ammonium sulfate, 2% glucose) for
1h. For nicotinamide (Sigma) treatment, cells grown to
log phase (OD600=1.0) in SC medium were treated with
5mM nicotinamide and incubated for 1h. All cultures
were incubated at 30 C.
Fluorescence microscopy
After rapamycin treatment or nitrogen starvation, ﬂuor-
escence microscopic analysis was performed on a Zeiss
Axiovert 200M inverted microscope as described earlier
(39). Nuclei in live cells were stained with 40,6-diamidino-
2-phenylindole (DAPI).
Chromatin immunoprecipitation and quantitative real-time
PCR analysis
Chromatin immunoprecipitation ChIP analysis was
performed as previously described (6) with some modiﬁ-
cations. After rapamycin treatment, nitrogen starvation or
nicotinamide treatment, yeast cultures were crosslinked
with 1% formaldehyde for 15min and quenched with
glycine at a ﬁnal concentration of 125mM for 5min at
room temperature. Cells were washed twice with cold
phosphate-buffered saline. Cell pellets were resuspended
in 500ml of lysis buffer (50mM HEPES–NaOH, pH 7.5,
140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 1mM phenylmethylsulfonyl
ﬂuoride, 1mM benzamidine, 1mg/ml leupeptin and
1mg/ml pepstatin) and bead-beated with 0.5mm glass
beads ten times for 1min at 4 C. Samples were incubated
on ice for 2min between bead beatings. Cell lysates were
sonicated ﬁve times for 15s with amplitude set at 20% and
centrifuged twice at 16000g for 10min. For TAP ChIP
experiments, 10ml of 50% slurry of pre-washed IgG–
agarose beads (Amersham Biosciences) was incubated
with 200ml of lysate at 4 C for 3h. For acetylated
histone H3 ChIP experiments, 200ml of lysate was
incubated at 4 C overnight with anti-acetyl Lys9/18
histone H3 (07-593; Upstate Biotechnology) and then
incubated with Protein A-agarose beads (Sigma) at 4 C
for 3h. Beads were washed twice in lysis buffer, once
with washing buffer I (50mM HEPES–NaOH, pH 7.5,
500mM NaCl, 1mM EDTA, 1% Triton X-100 and
0.1% sodium deoxycholate), once with washing buffer II
(10mM Tris–HCl, pH 8.0, 0.25M LiCl, 0.5% NP-40,
0.5% sodium deoxycholate and 1mM EDTA) and once
with TE buffer at room temperature. Beads were eluted by
adding 100ml of elution buffer (50mM Tris–HCl, pH 8.0,
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15min. Eluate was transferred to a fresh tube and pooled
with 150ml of TE containing 0.67% SDS. For input DNA,
200ml of elution buffer was added to 50ml of lysate. Input
and ChIP samples were incubated at 65 C overnight. All
samples were combined with 250ml of TE, 5mgo f
glycogen and 100mg of proteinase K, and incubated at
37 C for 2h. After addition of 55ml of 4M LiCl,
samples were extracted once with phenol:chloro-
form:isoamyl alcohol and once with chloroform.
Precipitated and washed DNA was resuspended in 100ml
of TE with 10mg of RNase A and incubated at 37 C for
1h. ChIP samples were analyzed by quantitative real-time
PCR using SYBR Green. Primers used for PCR were the
same as previously described (6). Relative fold enrichment
was determined by calculating the ratio of rDNA to
CUP1, an internal control, as follows: [rDNA(IP)/
CUP1(IP)]/[rDNA(input)/CUP1(input)]. Each set of ex-
periments was performed at least three times.
Western blot analysis
Whole-cell extracts were run on SDS–polyacrylamide gel
electrophoresis. Western blot analysis was performed by
standard methods using HRP-conjugated anti-mouse IgG
antibody (A9044; Sigma) for detection of TAP-tagged
proteins. Hexokinase was used as a loading control and
detected by anti-hexokinase antibody (H2035-02; United
States Biological).
Immunoprecipitation reactions
Reactions were performed as described earlier (13). For
immunoprecipitation of Sir2-Myc, mouse anti-Myc
antibody (sc-40; Santa Cruz Biotechnology) was added
to the cell extract and incubated at 4 C for 2h. Protein
A-agarose (Sigma) was then added to the reaction mixture
and incubated at 4 C for 1h. The immune complexes were
collected and loaded on SDS–polyacrylamide gels for
western blot analysis. Proteins were detected using
HRP-conjugated anti-HA antibody (sc-7392; Santa Cruz
Biotechnology) and rabbit anti-Myc antibody (06-549;
Upstate Biotechnology). Hexokinase was used as a
loading control and detected by anti-hexokinase
antibody (H2035-02; United States Biological).
Quantiﬁcation of mURA3 mRNA
Total RNA was isolated from yeast cells using the RNeasy
MiniKit (Qiagen). cDNA for reverse transcription–PCR
was generated using the ProtoScript First Strand cDNA
Synthesis Kit (New England Biolabs). The mURA3
silencing reporter gene, which contains the TRP1
promoter instead of the URA3 promoter, has been
described previously (40). The amount of mURA3 and
ACT1 mRNA was analyzed by quantitative real-time
reverse transcription–PCR using the Applied Biosystems
7300 Real-Time PCR system. Ampliﬁcation efﬁciencies
were validated and normalized against ACT1, and fold
increases were calculated using the 2
 C
T method (41).
Primers used for ampliﬁcation of mURA3 were 50-CTGTT
GACATTGCGAAGAGC-30 and 50-TCTCCCTTGTCA
TCTAAACC-30, and those for ACT1 were 50-TGACTG
ACTACTTGATGAAG-30 and 50-TGCATTTCTTGTTC
GAAGTC-30. All reactions were carried out in triplicate.
rDNA recombination assay
rDNA recombination rates were determined by measuring
the frequency of loss of ADE2 integrated at the rDNA
locus of strain DMY3010 as previously described (7).
Exponentially growing cells (OD600=1.0) in SC medium
were treated with or without 200ng/ml rapamycin for 1h,
sonicated brieﬂy to prevent aggregation and spread on SC
plates containing 5mM nicotinamide or not. Colonies
were allowed to grow for 2 days at 30 C and then
placed at 4 C for 2 days to enhance color development.
rDNA recombination rate was calculated by dividing the
number of half-red/half-white colonies by the total
number of colonies. Entirely red colonies were excluded
from all calculations. More than 20 000 colonies were
examined for each assay.
Analysis of replicative lifespan
Analysis of replicative lifespan was carried out by
micromanipulation as previously described (42), using a
Zeiss Tetrad Microscope. Lifespan analysis was per-
formed on YPD plates with or without 10ng/ml
rapamycin or 5mM nicotinamide. Cells that never
budded were excluded from calculation. For statistical
analysis, lifespan data sets were compared by a two-tailed
Wilcoxon Rank-Sum test. Lifespan was determined for
40 cells in each experiment.
RESULTS
Rapamycin treatment and nitrogen starvation cause
condensation of the nucleolus and enhance association of
Sir2 with rDNA
The yeast nucleolus normally appears as a crescent shape
localized at the periphery of the nucleus and is a dynamic
structure that can be altered by environmental condition
or stress. When TORC1 signaling is inhibited, nucleolar
size is rapidly reduced and rDNA undergoes condensation
(43). To examine the subcellular localization of rDNA
silencing factor Sir2 under TORC1 inhibition, we per-
formed ﬂuorescence microscopic analysis on cells in
which the endogenous SIR2 gene was modiﬁed to
produce C-terminal GFP fusion protein. For comparison,
we also analyzed the localization of Nop56-RFP, a
well-characterized nucleolar marker (44). Similar to
Nop56-RFP, Sir2-GFP formed a crescent-shaped struc-
ture and did not colocalize with the DNA-speciﬁc dye
DAPI, which is typically excluded from the nucleolus
during normal growth (Figure 1A). However, rapamycin
treatment and nitrogen starvation, conditions inhibiting
TORC1 signaling, caused reduction of the nucleolar size
and condensation of the ﬂuorescent signal of Sir2-GFP.
This morphological change of the nucleolus under
TORC1 inhibition has been reported to be accompanied
by release of Pol I components from the nucleolus (43).
Our results indicate that, unlike Pol I components, Sir2
1338 Nucleic Acids Research, 2011,Vol.39, No. 4remains stably associated with rDNA under TORC1
inhibition.
To gain insight into the relationship between rDNA
silencing factor Sir2 and TORC1 signaling, we analyzed
the binding of Sir2 to rDNA under rapamycin treatment
or nitrogen starvation. To obtain a high-resolution map
for this binding, we performed the ChIP experiment
followed by quantitative real-time PCR analysis using a
panel of 68 primers, which were designed to amplify frag-
ments of  0.25kb in length that span an entire 9.1-kb
rDNA unit (6). The structure of an rDNA repeat unit
and the PCR products analyzed in the ChIP assay are
shown in Figure 1B. We constructed yeast strains in
which the endogenous SIR2 gene was modiﬁed to
express C-terminal TAP fusion protein. After rapamycin
treatment or nitrogen starvation, Sir2-TAP was immuno-
precipitated using IgG-agarose beads from extracts con-
taining sheared chromatin. Whole-cell extract chromatin
and immunoprecipitated chromatin were used as template
DNA for quantitative real-time PCR. Consistent with the
previous report (6), Sir2 bound highly to the NTS1 and
NTS2/18S regions (Figure 1C). Remarkably, association
of Sir2 with rDNA increased over the entire rDNA locus
under rapamycin treatment and nitrogen starvation
compared to normal condition. This result indicates that
TORC1 inhibition by rapamycin treatment or nitrogen
starvation enhances association of Sir2 with rDNA array.
To test a possibility that enhanced association of Sir2
with rDNA might be due to increased expression of Sir2
under TORC1 inhibition, we examined the expression
level of Sir2 under rapamycin treatment or nitrogen star-
vation. Western blot analysis of whole-cell extracts
showed that the protein level of Sir2 did not increase
under rapamycin treatment or nitrogen starvation (data
not shown). This result indicates that the enrichment of
Sir2 at the rDNA region under TORC1 inhibition is not
due to increased protein level of Sir2. Therefore, we
conclude that inhibition of TORC1 signaling promotes
interaction between Sir2 and rDNA.
Inhibition of TORC1 signaling increases rDNA silencing
in a Sir2-dependent manner
Sir2 is a well-known rDNA silencing factor that
suppresses Pol II-dependent transcription at the rDNA
locus in S. cerevisiae (6). Enhanced association of Sir2
with rDNA under rapamycin treatment or nitrogen star-
vation raised a possibility that inhibition of TORC1 sig-
naling might increase rDNA silencing. To check this
possibility, we performed a spot assay using yeast strains
carrying the mURA3 silencing reporter gene inserted
either inside the NTS1 region of the rDNA locus
(RDN1-NTS1::mURA3) or outside the rDNA array
(leu2::mURA3) (35). Cells were 10-fold serially diluted
and spotted on SC medium or SC medium containing
5-ﬂuoroorotic acid (5-FOA), each with or without
rapamycin, to monitor silencing of mURA3. Consistent
with the previous observations (6,40), the mURA3
reporter gene was efﬁciently silenced at the NTS1, as
indicated by good growth on medium containing 5-FOA
(Supplementary Figure S1A, upper panel). In the presence
of rapamycin, overall cell growth was severely impaired on
SC medium, but cells carrying mURA3 within the NTS1
showed enhanced growth on SC medium containing
5-FOA (Supplementary Figure S1A, lower panel). This
observation suggests that TORC1 inhibition by rapamycin
treatment increases silencing of mURA3 at rDNA.
Additionally, to investigate the effect of TORC1 inhib-
ition on rDNA silencing more directly, we deleted TOR1
in strains carrying the mURA3 silencing reporter gene
inserted either inside the NTS1 region of the rDNA
locus (RDN1-NTS1::mURA3) or outside the rDNA
array (leu2::mURA3). Cells were 10-fold serially diluted
and spotted on SC medium as a plating control and on
medium without uracil or with 5-FOA to monitor
silencing of mURA3. As expected, the reporter gene was
efﬁciently silenced at the NTS1 in wild-type cells, as
indicated by poor growth on medium lacking uracil or
by good growth on medium containing 5-FOA
(Supplementary Figure S1B). In tor1 cells, the reporter
gene was further silenced at the NTS1, as indicated by
poorer growth on medium lacking uracil or by better
growth on medium containing 5-FOA compared to
wild-type cells. These results indicate that inhibition of
TORC1 signaling increases rDNA silencing.
To further examine rDNA silencing under TORC1 in-
hibition, we analyzed transcription of the mURA3
silencing reporter gene integrated at the rDNA locus.
We performed a real-time reverse transcription–PCR
analysis to directly measure the transcript levels of the
Pol II-transcribed mURA3 gene inserted either inside the
NTS1 region of the rDNA locus (RDN1-NTS1::mURA3)
or outside the rDNA array (leu2::mURA3). In normally
growing wild-type cells, the reporter mURA3 gene was
efﬁciently silenced at the rDNA locus (>40%) compared
to outside rDNA (Figure 2A). As expected, silencing of
the reporter gene at the rDNA locus was almost complete-
ly abolished in normally growing sir2 cells. Interestingly,
in wild-type cells under rapamycin treatment or nitrogen
starvation, silencing of the mURA3 gene at the rDNA
locus increased considerably (>70%) compared to
outside rDNA. However, the relative transcript levels of
mURA3 in sir2D cells under rapamycin treatment and
nitrogen starvation were similar to those in normally
growing sir2D cells. These results indicate that inhibition
of TORC1 signaling increases rDNA silencing, which is
dependent on the presence of Sir2.
To conﬁrm that increase of rDNA silencing under
TORC1 inhibition is mediated by Sir2, we measured the
transcript levels of the mURA3 reporter gene under treat-
ment of nicotinamide, a well-known inhibitor of the
enzymaticactivityofSir2(45,46).Consistentwiththeprevi-
ous report (45,46), nicotinamide inhibited the histone
deacetylase activity of Sir2 in vitro (Supplementary
Figure S2A). As expected, nicotinamide treatment consid-
erably abolished silencing of the reporter gene at the rDNA
locus (Figure 2B; see also Supplementary Figure S2B),
demonstrating that Sir2 plays critical roles in rDNA
silencing. Interestingly, when nicotinamide and rapamycin
were co-treated to cells, silencing of the reporter gene at
the rDNA locus was also abolished, suggesting that the
inhibitory effect of nicotinamide on rDNA silencing
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Figure 1. TORC1 inhibition leads to condensation of the nucleolus and enhancement of association of Sir2 with rDNA. (A) Rapamycin treatment
and nitrogen starvation cause reduction of the nucleolar size and condensation of the Sir2-GFP signal. Subcellular localization of Sir2-GFP (green)
and Nop56-RFP (red) was analyzed after treatment with 200ng/ml rapamycin or incubation in nitrogen-depleted medium for 1h. DAPI staining for
visualization of the nucleus (blue) and differential interference contrast (DIC) images are also shown. (B) The structure of the tandemly repeating
rDNA of S. cerevisiae is shown above, and a single 9.1-kb rDNA unit is shown expanded below. PCR products analyzed in the ChIP assays are
indicated below the rDNA unit. (C) Rapamycin treatment and nitrogen starvation enhance association of Sir2 with rDNA. The degree of Sir2
binding to rDNA was measured using the ChIP assay after treatment with 200ng/ml rapamycin (upper panel) or incubation in nitrogen-depleted
medium for 1h (lower panel). For control, cells were treated with DMSO only (upper panel) or grown in SC medium (lower panel). Relative fold
enrichment refers to the relative ratio of PCR products ampliﬁed from immunoprecipitated DNA to products from whole-cell extract DNA. Values
represent the average of three independent experiments and error bars indicate standard deviations.
1340 Nucleic Acids Research, 2011,Vol.39, No. 4A
0
20
40
60
80
100
Control Rapa NAM NAM+Rapa
0
20
40
60
80
100
WT sir2Δ
B
C
E
D
R
e
l
a
t
i
v
e
 
m
U
R
A
3
 
t
r
a
n
s
c
r
i
p
t
 
l
e
v
e
l
(
N
T
S
1
/
l
e
u
2
)
 
R
e
l
a
t
i
v
e
 
m
U
R
A
3
t
r
a
n
s
c
r
i
p
t
 
l
e
v
e
l
(
N
T
S
1
/
l
e
u
2
)
 
Control
Rapamycin
N starvation
0
2
4
6
8
10
25S NTS1 NTS2/18S 18S
Control
Rapa
NAM
NAM + Rapa
R
e
l
a
t
i
v
e
 
f
o
l
d
 
e
n
r
i
c
h
m
e
n
t Sir2-TAP ChIP
0
2
4
6
8
10
12
NAM
Control
Rapa
Rapa ˜NAM
NAM˜Rapa
25S NTS1 NTS2/18S 18S
R
e
l
a
t
i
v
e
 
f
o
l
d
 
e
n
r
i
c
h
m
e
n
t Sir2-TAP ChIP
0
2
4
6
8
10
Control
Rapa
NAM
NAM + Rapa
25S NTS1 NTS2/18S 18S
R
e
l
a
t
i
v
e
 
f
o
l
d
 
e
n
r
i
c
h
m
e
n
t a-diAcH3 ChIP
Figure 2. Inhibition of TORC1 signaling enhances rDNA silencing and histone deacetylation at rDNA in a Sir2-dependent manner. (A) Rapamycin
treatment and nitrogen starvation promotes transcriptional silencing of the mURA3 reporter gene at the rDNA locus in a Sir2-dependent manner.
Total RNA was extracted from wild-type (WT) and sir2 cells after treatment with 200ng/ml rapamycin or incubation in nitrogen-depleted medium
for 1h. Quantitative real-time reverse transcription–PCR analysis was performed to measure the transcript levels of the mURA3 reporter gene
inserted either inside the NTS1 region or outside the rDNA array. Ampliﬁcation efﬁciencies were validated and normalized against ACT1. Relative
mURA3 transcript levels were calculated as the ratio of the normalized transcript level of the mURA3 reporter gene inside the NTS1 region to that
outside the rDNA array. (B) Nicotinamide abolishes silencing of the mURA3 reporter gene at the rDNA locus. Total RNA was extracted from
wild-type cells after treatment with 200ng/ml rapamycin (Rapa), 5mM nicotinamide (NAM), or both (NAM+Rapa) for 1h. Relative mURA3
transcript levels were calculated as described above. (C) Association of Sir2 with rDNA is not enhanced by rapamycin under nicotinamide treatment.
The degree of Sir2 binding to four representative regions in the rDNA (25S, NTS1, NTS2/18S and 18S regions) was measured using the ChIP assay
Nucleic Acids Research,2011, Vol.39, No. 4 1341overrides the stimulatory effect of TORC1 inhibition on
rDNA silencing. When the expression level of Sir2 was
measured under nicotinamide treatment, no difference
was observed whether nicotinamide was treated or not
(data not shown), indicating that nicotinamide does not
interfere with the expression of Sir2 and, therefore,
the effect of nicotinamide on rDNA silencing results from
inhibition of the Sir2 activity.
We next analyzed the effect of nicotinamide on associ-
ation of Sir2 with rDNA. For this analysis, we performed
the ChIP experiment for four representative regions in the
rDNA locus—25S, NTS1, NTS2/18S and 18S regions
(corresponding to the PCR products 3, 15, 23 and 30,
respectively; see Figure 1B). Under nicotinamide treat-
ment, the degree of binding of Sir2 to rDNA was essen-
tially unchanged whether rapamycin was co-treated or not
(Figure 2C). This result correlates well with the observa-
tion that silencing of the mURA3 reporter gene at the
NTS1 region of the rDNA locus was relieved by nicotina-
mide even under rapamycin treatment (Figure 2B). The
observation that the degree of Sir2 binding to rDNA
was neither decreased nor increased by nicotinamide
raised a possibility that, although nicotinamide inhibits
the activity of Sir2, it may not affect the already-
established association of Sir2 with rDNA. To check
this possibility, we assayed whether enhanced association
of Sir2 with rDNA by rapamycin would be maintained
upon later treatment of nicotinamide. Interestingly, we
observed that enhanced association of Sir2 with rDNA
by rapamycin was not affected by later treatment of nico-
tinamide (Figure 2D), indicating that nicotinamide does
not disturb the already-established association of Sir2 with
rDNA. However, silencing of the mURA3 reporter gene at
the NTS1 region of the rDNA locus was still abolished
under this condition (Supplementary Figure S2C). When
nicotinamide was treated before rapamycin, enhancement
of association of Sir2 with rDNA was not observed
(Figure 2D), suggesting that, upon inactivation by nico-
tinamide, rDNA-unbound form of Sir2 does not respond
to rapamycin and is no longer recruited to rDNA.
We also measured the acetylation level of histone H3
associated with the rDNA regions. Based on the fact that
Sir2 is a histone deacetylase (9,10), we expected that the
acetylation level of histone H3 at rDNA would be recip-
rocally proportional to the enzymatic activity of Sir2. As
expected, the acetylation level of H3 was lowest in the
NTS1 region where the degree of binding of Sir2 to
rDNA was highest whether rapamycin was treated or
not (Figure 2E). When cells were treated with nicotina-
mide, the H3 acetylation level increased signiﬁcantly in
all regions of the rDNA locus, correlating with the
previous report that deletion of SIR2 causes an increase
in the H3 acetylation level throughout the rDNA regions
(6). This effect of nicotinamide on the H3 acetylation level
was still observed even under rapamycin treatment. Taken
together, these results indicate that Sir2 is crucial for
increasing rDNA silencing under inhibition of TORC1
signaling and nicotinamide negatively regulates rDNA
silencing.
Inhibition of TORC1 signaling promotes rDNA stability
and extends lifespan in yeast
Based on the results that inhibition of TORC1 signaling
enhances association of Sir2 with rDNA and increases
rDNA silencing, we examined if TORC1 inhibition
could reduce rDNA recombination by promoting rDNA
stability. To measure the rDNA recombination rate under
TORC1 inhibition, the frequency of loss of the ADE2
marker gene integrated at the rDNA locus was monitored
under rapamycin treatment. Colonies in which the ADE2
marker has been lost accumulate a red pigment, while
colonies that maintain and express ADE2, which is
weakly silenced in rDNA, remain white. A marker loss
event during the ﬁrst division after plating results in
half-red/half-white colonies. Thus, rDNA recombination
rate can be determined by dividing the number of half-red/
half-white colonies by the total number of colonies (7,35).
In accordance with the observation that TORC1 inhib-
ition increases rDNA silencing, cells treated with
rapamycin showed a decreased rate of marker loss
compared to control cells (Figure 3A). This result demon-
strates that TORC1 inhibition suppresses rDNA recom-
bination and promotes rDNA stability. In contrast,
nicotinamide treatment increased the rate of rDNA re-
combination. rDNA recombination was still increased
when cells were co-treated with rapamycin and nicotina-
mide, indicating that enzymatically active Sir2 is critical
for suppression of rDNA recombination under inhibition
of TORC1 signaling. Taken together with the previous
data, this result suggests that inhibition of TORC1 signal-
ing suppresses rDNA recombination and promotes rDNA
stability by enhancing association of Sir2 with rDNA.
It has been reported that rDNA recombination leads to
the formation of extrachromosomal rDNA circles that are
toxic to cells and induce cell aging (5), and TORC1 inhib-
ition increases replicative lifespan in yeast (29,30). Our
result showing that TORC1 inhibition suppresses rDNA
recombination and promotes rDNA stability provides a
clue as to why TORC1 inhibition increases replicative
lifespan in yeast. To conﬁrm that replicative lifespan ex-
tension by TORC1 inhibition is closely related to
increased rDNA silencing and rDNA stability resulting
from enhanced association of Sir2 with rDNA, we per-
formed the replicative lifespan analysis under treatment
of rapamycin, nicotinamide, or both. As shown in
after treatment with 200ng/ml rapamycin (Rapa), 5mM nicotinamide (NAM), or both (NAM+Rapa) for 1h. (D) Nicotinamide does not disturb the
already-established association of Sir2 with rDNA. The degree of Sir2 binding to rDNA was measured using the ChIP assay after the following
treatments: 200ng/ml rapamycin for 1h (Rapa), 5mM nicotinamide for 1h (NAM), 5mM nicotinamide for 1h and then 200ng/ml rapamycin for 1h
(NAM!Rapa), 200ng/ml rapamycin for 1h and then 5mM nicotinamide for 1h (Rapa!NAM). (E) The acetylation level of histone H3 at rDNA
is reciprocally proportional to the enzymatic activity of Sir2. The acetylation level of histone H3 associated with the rDNA regions was measured
using the ChIP assay after treatment with 200ng/ml rapamycin (Rapa), 5mM nicotinamide (NAM), or both (NAM+Rapa) for 1h. For control,
cells were treated with DMSO only. Values represent the average of three independent experiments and error bars indicate standard deviations.
1342 Nucleic Acids Research, 2011,Vol.39, No. 4Figure 3B, rapamycin signiﬁcantly extended replicative
lifespan of cells. In contrast, nicotinamide accelerated
aging of cells. When rapamycin and nicotinamide were
co-treated to cells, nicotinamide abolished the stimulatory
effect of rapamycin on lifespan extension. These results
correlate well with the effects of rapamycin and nicotina-
mide on rDNA silencing (Figure 2B) and rDNA stability
(Figure 3A). Consistent with the previous report (7),
deletion of SIR2 caused reduction in replicative lifespan
of cells (Figure 3C and D). In sir2 cells, replicative
lifespan was not increased under TORC1 inhibition by
TOR1 deletion (Figure 3C) or rapamycin treatment
(Figure 3D). Taken together, our data suggest that inhib-
ition of TORC1 signaling increases rDNA silencing and
rDNA stability by enhancing association of Sir2 with
rDNA, thereby leading to extension of replicative
lifespan in yeast.
Overexpression of PNC1 and SIR2 enhances association
of Sir2 with rDNA and decreases the acetylation level of
histone H3 at rDNA
The PNC1 gene encodes a nicotinamidase that converts
nicotinamide to nicotinic acid as part of the NAD
+
salvage pathway (47). Therefore, deletion of PNC1
results in an elevated level of nicotinamide in cells that
can inhibit the Sir2 activity. It has been shown that
calorie restriction and other mild stresses extend yeast
lifespan by increasing expression of PNC1 (46,48). A
recent study has reported that inhibition of TORC1 sig-
naling by rapamycin also promotes expression of PNC1
(30). Our results showing that rapamycin enhances asso-
ciation of Sir2 with rDNA and lowers the H3 acetylation
level at rDNA raised a possibility that overexpression of
PNC1 would have the same effect of rapamycin on rDNA.
To check this possibility, we analyzed the degree of Sir2
binding to rDNA and the H3 acetylation level at rDNA in
cells where PNC1 was deleted or overexpressed. In pnc1
cells, the degree of Sir2 binding to rDNA was essentially
unchanged (Figure 4A), but the H3 acetylation level at
rDNA increased considerably compared to wild-type
cells (Figure 4B). In contrast, overexpression of PNC1
increased binding of Sir2 to rDNA (Figure 4A) and
lowered the H3 acetylation level at rDNA (Figure 4B).
Whether PNC1 was deleted or overexpressed, the
protein level of Sir2 was not changed (data not shown).
This result demonstrates that overexpression of PNC1 and
rapamycin treatment exert the same effect on rDNA and
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Figure 3. TORC1 inhibition promotes rDNA stability and extends
lifespan in yeast. (A) Inhibition of TORC1 signaling suppresses
rDNA recombination. rDNA recombination is represented by the
rate of loss of the ADE2 marker gene integrated at the rDNA locus,
which was calculated as the ratio of half-sectored colonies to the total
number of colonies (‘Materials and Methods’ section). Exponentially
growing cells were treated with or without 200ng/ml rapamycin for 1h
and plated on SC plates containing 5mM nicotinamide or not. After
color development, the number of half-red/half-white colonies was
counted and divided by the total number of colonies. Entirely red
colonies have lost the marker prior to plating and thus were excluded
from the total number of colonies. Values represent the average of
three independent experiments and error bars indicate standard
deviations. (B) Rapamycin extends replicative lifespan of cells,
whereas nicotinamide accelerates aging of cells. The P-values for
10ng/ml rapamycin (Rapa), 5mM nicotinamide (NAM) and both
treatment (Rapa+NAM) versus DMSO only (Control) are
3.7 10
 3, 3.3 10
 6 and 7.8 10
 6, respectively. (C) Deletion of
TOR1 fails to increase the lifespan of sir2 cells. The P-values for
tor1, sir2, and tor1 sir2 cells versus wild-type cells (WT)
are 5.8 10
 4, 2.7 10
 7, and 4.3 10
 7, respectively. (D)
Rapamycin fails to increase the lifespan of sir2 cells. The P-values
for wild-type cells treated with 10ng/ml rapamycin (WT+Rapa), sir2,
and sir2 cells treated with 10ng/ml rapamycin (sir2+Rapa) versus
wild-type cells (WT) are 4.8 10
 4, 2.7 10
 7 and 2.3 10
 6, respect-
ively. Replicative lifespan was determined by scoring the number of
daughter cells produced by each mother cell. Mean lifespans are
shown in parentheses.
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Figure 4. Pnc1 is required for enhancement of Sir2 binding to rDNA under TORC1 inhibition. (A) PNC1 overexpression enhances association of
Sir2 with rDNA. The degree of Sir2 binding to rDNA was measured using the ChIP assay in wild-type, pnc1, pnc1 cells containing an empty
vector and pnc1 cells expressing Pnc1-GFP on the p416GPD vector. (B) PNC1 overexpression lowers the H3 acetylation level at rDNA. The
acetylation level of histone H3 at the rDNA regions was measured using the ChIP assay in wild-type, pnc1, pnc1 cells containing an empty vector
1344 Nucleic Acids Research, 2011,Vol.39, No. 4suggests that enhancement of association of Sir2 with
rDNA is a common mechanism underlying extension of
lifespan in yeast by calorie restriction, other mild stresses,
or TORC1 inhibition.
It is well established that increased dosage of the SIR2
gene extends lifespan in several organisms (7,49,50). To
examine whether association of Sir2 with rDNA would
be enhanced by overexpression of SIR2, we measured
the degree of Sir2 binding to rDNA and the H3 acetyl-
ation level at rDNA in cells where SIR2 was
overexpressed. For this experiment, we used sir2 cells
with ectopically expressing TAP-tagged Sir2 to exclude
the interfering effect of untagged Sir2 on the ChIP
assay. In cells overexpressing Sir2, association of Sir2
with rDNA was considerably enhanced throughout the
rDNA region (Figure 4C). Correlating with this observa-
tion, the H3 acetylation level at rDNA was signiﬁcantly
lowered in those cells (Figure 4D). This result corrobor-
ates the notion that enhancement of association of Sir2
with rDNA is a common mechanism underlying extension
of lifespan in yeast by calorie restriction, TORC1 inhib-
ition, or SIR2 overexpression.
Upon loss of PNC1, rapamycin cannot increase
association of Sir2 with rDNA and histone
deacetylation at rDNA
We have shown that inhibition of TORC1 signaling
enhances association of Sir2 with rDNA and increases
histone deacetylation at rDNA. Recently, it has been
reported that TORC1 inhibition extends lifespan by
relocalizing two transcription factors, Msn2 and Msn4,
from the cytoplasm to the nucleus, where they activate
expression of Pnc1 (30). Increased Pnc1 level would then
lead to reduction of intracellular nicotinamide and conse-
quent increase of the Sir2 activity. Taking into account
these facts, we hypothesized that increased expression of
Pnc1 would be a prerequisite for enhancement of associ-
ation of Sir2 with rDNA under TORC1 inhibition. To
examine this hypothesis, we measured the degree of Sir2
binding to rDNA and the H3 acetylation level at rDNA in
pnc1 cells under rapamycin treatment. When pnc1 cells
were treated with rapamycin, we could not observe any
enhancement of Sir2 binding to rDNA (Figure 4E).
Correlating with this result, rapamycin could not lower
the H3 acetylation level at rDNA in pnc1 cells
(Figure 4F). Deletion of PNC1 or treatment of rapamycin
did not change the protein level of Sir2 (data not shown).
The patterns of Sir2 binding to rDNA and histone
deacetylation at rDNA in pnc1 cells under rapamycin
treatment were very similar to those observed in cells
co-treated with nicotinamide and rapamycin (Figure 2C
and E). These results suggest that reduction of nicotina-
mide by increased Pnc1 is required for enhancement of
Sir2 binding to rDNA and increase of histone
deacetylation at rDNA under TORC1 inhibition.
Net1 is required for enhancement of association of Sir2
with rDNA under TORC1 inhibition
In yeast, Sir2 is found as a subunit of an rDNA silencing
complex called RENT (12). This complex is tethered to the
nucleolus by its core subunit Net1. Net1 is required for
association of Sir2 with rDNA, but association of Net1
with rDNA is independent of Sir2 (13). Since association
of Sir2 with rDNA is dependent on Net1, we asked
whether Net1 would also be required for enhanced asso-
ciation of Sir2 with rDNA under TORC1 inhibition. To
test this possibility, we ﬁrst analyzed the subcellular local-
ization of Net1 under TORC1 inhibition. Rapamycin
treatment and nitrogen starvation led to condensation of
the ﬂuorescent signal of Net1-GFP (Figure 5A). This ob-
servation suggests that, similar to Sir2, Net1 remains
stably associated with rDNA under TORC1 inhibition.
Moreover, association of Net1 with rDNA increased
over the entire rDNA locus under rapamycin treatment
and nitrogen starvation (Figure 5B). The protein level of
Net1 was not changed under these conditions (data not
shown). Together, these results indicate that TORC1 in-
hibition enhances association of not only Sir2 but also
Net1 with rDNA array.
We next examined the degree of binding of Sir2 to
rDNA under rapamycin treatment in cells where NET1
was deleted. Interestingly, when net1 cells were treated
with rapamycin, we could not observe any enhancement of
Sir2 binding to rDNA (Figure 5C). Whether NET1 was
deleted or not, the protein level of Sir2 was not altered
(data not shown). This result demonstrates that Net1 is
required for enhancement of Sir2 binding to rDNA under
TORC1 inhibition.
As shown in Figure 4A, overexpression of Pnc1
enhances Sir2 binding to rDNA. To determine whether
the Pnc1 activity would inﬂuence association of Net1
with rDNA, we examined the degree of Net1 binding to
rDNA under rapamycin treatment in cells where PNC1
was deleted. There was little difference in the degree of
Net1 binding to rDNA between wild-type and pnc1
cells under normal condition (Figure 5D). When
rapamycin was treated, association of Net1 with rDNA
was considerably enhanced in pnc1 cells as well as in
wild-type cells. This result indicates that the Pnc1
activity does not affect association of Net1 with rDNA
whether rapamycin is present or not. This binding
pattern of Net1 is contrasting to that of Sir2, which does
and pnc1 cells expressing Pnc1-GFP on the p416GPD vector. (C) SIR2 overexpression enhances association of Sir2 with rDNA. The degree of Sir2
binding to rDNA was measured using the ChIP assay in wild-type and sir2 cells expressing Sir2-TAP on the p416GPD vector. (D) SIR2
overexpression lowers the H3 acetylation level at rDNA. The acetylation level of histone H3 at the rDNA regions was measured using the ChIP
assay in wild-type and sir2 cells expressing Sir2-TAP on the p416GPD vector. (E) Rapamycin does not enhance association of Sir2 with rDNA in
pnc1 cells. The degree of Sir2 binding to rDNA was measured using the ChIP assay in wild-type and pnc1 cells after treatment with or without
200ng/ml rapamycin for 1h. (F) Rapamycin does not lower the H3 acetylation level at rDNA in pnc1 cells. The acetylation level of histone H3 at
the rDNA regions was measured using the ChIP assay in wild-type and pnc1 cells after treatment with or without 200ng/ml rapamycin for 1h.
Values represent the average of three independent experiments and error bars indicate standard deviations.
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Figure 5. Net1 is required for enhancement of association of Sir2 with rDNA under TORC1 inhibition. (A) Rapamycin treatment and nitrogen
starvation cause condensation of the Net1-GFP signal. Subcellular localization of Net1-GFP (green) and Nop56-RFP (red) was analyzed after
treatment with 200ng/ml rapamycin or incubation in nitrogen-depleted medium for 1h. DAPI staining for visualization of the nucleus (blue) and
DIC images are also shown. (B) Rapamycin treatment and nitrogen starvation enhance association of Net1 with rDNA. The degree of Net1 binding
to rDNA was measured using the ChIP assay after treatment with 200ng/ml rapamycin (upper panel) or incubation in nitrogen-depleted medium for
1346 Nucleic Acids Research, 2011,Vol.39, No. 4not show any enhancement of binding to rDNA in pnc1
cells even when rapamycin is present (Figure 4E).
We next asked whether rapamycin would inﬂuence
interaction between Net1 and Sir2. To examine interaction
between Net1 and Sir2, we constructed yeast strains in
which the endogenous NET1 and SIR2 genes were
modiﬁed to express C-terminal HA and Myc fusion
proteins, respectively. Remarkably, coprecipitation of
Net1 and Sir2 was signiﬁcantly increased under rapamycin
treatment (Figure 5E). This observation indicates that
TORC1 inhibition enhances interaction between Net1
and Sir2. In pnc1 cells, however, coprecipitation of
Net1 and Sir2 was only marginally increased under
rapamycin treatment, indicating that enhancement of
interaction between Net1 and Sir2 under TORC1 inhib-
ition is dependent on the Pnc1 activity and only the active
form of Sir2 can be bound to Net1 under TORC1 inhib-
ition. Taken together with the previous data, these results
suggest that enhancement of Sir2 binding to rDNA under
TORC1 inhibition is due to increased association of Net1
with rDNA and enhanced interaction between Net1 and
Sir2.
DISCUSSION
Inhibition of TORC1 signaling by rapamycin can delay
aging and extend lifespan in several organisms.
However, the mechanism by which inhibition of TORC1
signaling delays aging and extends lifespan is poorly
understood. A recent study has shown that calorie restric-
tion and TORC1 inhibition promote the activity of Sir2 by
relocalizing the transcription factors Msn2 and Msn4
from the cytoplasm to the nucleus, where they increase
expression of PNC1 encoding a nicotinamidase that
depletes cellular nicotinamide, a physiological inhibitor
of Sir2 (30). Taken together with the fact that increase
of the Sir2 activity extends lifespan in yeast (7), it is
likely that extension of lifespan by TORC1 inhibition is
due to the promoted activity of Sir2. Our results support
this notion and provide insight into the molecular mech-
anism underlying promotion of the Sir2 activity by
TORC1 inhibition. We have shown that inhibition of
TORC1 signaling enhances association of Sir2 with
rDNA (Figure 1), promotes transcriptional silencing of
Pol II-transcribed gene at the rDNA locus and induces
deacetylation of histones at rDNA (Figure 2).
Furthermore, we have shown that TORC1 inhibition
reduces homologous recombination between rDNA
repeats and extends replicative lifespan (Figure 3), and
Pnc1 and Net1 are required for enhancement of Sir2
binding to rDNA under TORC1 inhibition (Figures 4
and 5). Our results provide evidence that TORC1
inhibition stabilizes the rDNA locus and increases
rDNA silencing by enhancing association of Sir2 with
rDNA, thereby leading to lifespan extension in yeast.
It is well known that accumulation of extrachromosom-
al rDNA circles is toxic to cells and induces replicative
aging in yeast (5). Extrachromosomal rDNA circles are
formed by homologous recombination within the rDNA.
The replication fork block protein Fob1 promotes rDNA
recombination and formation of extrachromosomal
rDNA circles (16,17). Therefore, deletion of FOB1
extends replicative lifespan in yeast (51). We observed
that inhibition of TORC1 by rapamycin resulted in an
additive increase of replicative lifespan when combined
with deletion of FOB1 (Supplementary Figure S3),
which is consistent with the previous report that deletion
of TOR1 increases replicative lifespan additively with
deletion of FOB1 (29). This observation suggests that
TORC1 inhibition may contribute to lifespan extension
by additional mechanisms other than promotion of
rDNA silencing and rDNA stability by enhancing associ-
ation of Sir2 with rDNA. Recent studies have reported
that Sir2 promotes replicative lifespan in yeast by add-
itional non-rDNA mechanisms. It has been shown that
Sir2 is required for asymmetric retention of damaged cyto-
plasmic proteins in the mother cell, resulting in an
enhanced capacity to respond to oxidative stress in the
daughter cell (52,53). Another non-rDNA function of
Sir2 suggested to contribute to longevity is maintenance
of telomeric chromatin. Dang et al. (54) showed that Sir2
abundance declines in replicatively old yeast cells and that
this loss of Sir2 is accompanied by a decrease in histone
acetylation and histone abundance near telomeres.
Whether TORC1 signaling modulates these non-rDNA
functions of Sir2 is not known yet. Further studies are
needed to establish if TORC1 inhibition contributes to
lifespan extension by regulating these non-rDNA func-
tions of Sir2, in addition to by promoting rDNA silencing
and rDNA stability.
Recently, it has been reported that deletion of genes
encoding many of 60S subunit ribosomal proteins are
each sufﬁcient to signiﬁcantly increase lifespan in yeast
(55). Deletion of some ribosomal protein genes results in
lifespan extension exceeding 50% (e.g. 90.9 and 60.9% in
rpl22a and rpl13a cells, respectively). Deletion of some
other ribosomal proteins has no effect on lifespan or
rather results in lifespan shortening (e.g.  8.8% in
rpl35b cells). To test a possibility that lifespan extension
by depletion of 60S ribosomal proteins might has any
relation to enhanced association of Sir2 with rDNA, we
examined the degree of Sir2 binding to rDNA in rpl22a
and rpl13a cells. These mutant cells did not show
signiﬁcant change in Sir2 binding to rDNA compared to
1h (lower panel). For control, cells were treated with DMSO only (upper panel) or grown in SC medium (lower panel). (C) Rapamycin does not
enhance association of Sir2 with rDNA in net1 cells. The degree of Sir2 binding to rDNA was measured using the ChIP assay in wild-type and
net1 cells after treatment with or without 200ng/ml rapamycin for 1h. (D) Association of Net1 with rDNA is not affected by Pnc1. The degree of
Net1 binding to rDNA was measured using the ChIP assay in wild-type and pnc1 cells after treatment with or without 200ng/ml rapamycin for 1h.
Values represent the average of three independent experiments and error bars indicate standard deviations. (E) TORC1 inhibition enhances
interaction between Net1 and Sir2. Interaction between Net1 and Sir2 was analyzed by coimmunoprecipitation in wild-type and pnc1 cells after
treatment with or without 200ng/ml rapamycin for 1h. Hexokinase was used as a loading control. The levels of Net1-HA coimmunoprecipitated
with Sir2-Myc were quantiﬁed and indicated below the respective lanes.
Nucleic Acids Research,2011, Vol.39, No. 4 1347that of wild-type or rpl35b cells (Supplementary Figure
S4). In addition, the protein level of Sir2 was not changed
in these mutant cells (data not shown). This observation
indicates that depletion of 60S ribosomal proteins extends
lifespan by mechanisms different from promotion of
rDNA silencing and rDNA stability by Sir2 and
suggests that multiple pathways act in parallel to
promote lifespan in yeast.
Saccharoymyces cerevisiae contains four additional
proteins homologous to Sir2 (Hst1, Hst2, Hst3 and
Hst4), some of which have been reported to have func-
tional redundancy with Sir2. For example, Hst2 can com-
pensate for the lack of Sir2 during calorie restriction (56).
Nicotinamide has been shown to inhibit not only Sir2 but
also Hst1 and Hst2 (46,57). Under the experimental con-
ditions and with the strains used in this study, we have
observed that nicotinamide treatment abolishes silencing
of the reporter mURA3 gene at the rDNA locus to an
extent similar to that of deletion of SIR2 (Figure 2A
and B). This observation suggests that Sir2 plays a
major role in rDNA silencing while Hst1 and Hst2 make
a minor contribution to rDNA silencing. Consistent with
this notion, the ChIP assay revealed that Hst1 and Hst2
were not associated with the rDNA regions whether
rapamycin was treated or not (data not shown). A
previous study has also reported that deletion of HST1
and HST2 has a very minor effect on rDNA silencing (58).
In contrast, deletion of HST2 has been shown to signiﬁ-
cantly increase the rDNA recombination rate (56). Since
functional redundancy between Sir2 and Hst proteins in
rDNA silencing remains controversial, further investiga-
tion and comparison of the action mechanisms of Sir2 and
Hst proteins should be useful in resolving the controversy
over functional redundancy between them.
Intriguingly, we observed that the rDNA-binding
pattern of Net1 under nitrogen starvation is slightly
different from that of Sir2 under the same condition
(Figures 1C and 5B). Under nitrogen starvation, Net1
most strongly bound to the NTS2/18S region, whereas
Sir2 most strongly bound to the NTS1 region. It is
widely accepted that rapamycin treatment induces
similar responses in eukaryotic cells as under condition
of nitrogen depletion (59). However, it is reasonable to
assume that the response of cells to nitrogen depletion
would be slightly different from that to rapamycin treat-
ment. This is because rapamycin directly exerts its inhibi-
tory effect on TORC1 via Fpr1 but not on the upstream
effectors of TORC1 (60), whereas nitrogen depletion shuts
down amino acid signaling (61), which may affect the
upstream effectors of TORC1. Stp1, a well-known tran-
scription factor that regulates the expression of several
amino acid permease genes, represents a clear example
of the differences between response of cells to nitrogen
depletion and that to rapamycin treatment (62). It is pre-
sumable that some unknown upstream effectors of
TORC1 may differentially inﬂuence the rDNA-binding
activity of Net1 and Sir2.
Since Sir2 was shown to extend lifespan of budding
yeast by repressing genome instability (5,7), Sir2-like
proteins, or sirtuins, have been found in organisms
ranging from bacteria to humans (63,64). Mammals
contain seven sirtuins, SIRT1-7 (64). Human SIRT1 has
been shown to deacetylate H3 at rDNA repeats (65).
Recently, it has been reported that nuclear SIRT1 is re-
cruited to the nucleolar compartment dynamically (66)
and is associated with chromatin throughout the rDNA
locus (67). Moreover, a nucleolar sirtuin SIRT7 associates
with the rDNA locus, interacts with RNA Pol I and acti-
vates rRNA transcription (68). Presumably, enhancement
of association of Sir2 and some sirtuins with rDNA may
be a common mechanism underlying increase of rDNA
stability and extension of lifespan among yeast and
higher organisms. It remains to be determined whether
TORC1 inhibition by rapamycin would also enhance as-
sociation of sirtuins with rDNA, thereby stabilizing the
rDNA locus and increasing rDNA silencing in higher or-
ganisms. Recent studies have shown that mammalian
nicotinamide phosphoribosyltransferase (Nampt/PBEF/
Visfatin), a putative functional ortholog of Pnc1 that is
required for conversion of nicotinamide to NAD
+, posi-
tively regulates sirtuin activity (69,70). It would also be
interesting to check if association of sirtuin proteins with
rDNA is enhanced in mammalian cells overexpressing
nicotinamide phosphoribosyltransferase.
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